VALTREX(Valacyclovir) Once Daily for Viral Shedding In Subjects Newly Diagnosed With HSV-2

Clinical trial NCT00306293 · COMPLETED

Trial details

NCT number: NCT00306293
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Herpes Labialis

Start date: 2006-02-20
Primary completion: 2006-11-27
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.